Miocamycin is a macrolide type antimicrobial . This drug may be marketed in Japan for clinical use as it is listed in the Japanese pharmacopeia . It has shown to... It has shown to be effective against several gram-positive and gram-negative microbes and may be useful in the treatment of upper and lower respiratory tract infections, and urogenital tract infections or as an alternative to...
- Mechanism
- Curator reviewed · 1 reference
Miocamycin is a macrolide antibiotic, which inhibits bacterial protein synthesis by binding the 50S ribosomal subunit (23S rRNA region), blocking elongation.
- Also known as
- Midecamycin acetate
Resolves to
What you can answer from here — as of September 21, 2026
Which other approved drugs treat the same conditions as Miocamycin, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account